Astera Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Cash & Equivalents	45.1	76.09
Short-Term Investments	104.22	87.06
Cash & Cash Equivalents	149.31	163.14
Cash Growth	-8.48%	-
Receivables	8.34	10.72
Inventory	24.1	28.87
Other Current Assets	4.06	3.27
Total Current Assets	185.81	206.01
Property, Plant & Equipment	4.71	3.52
Other Long-Term Assets	5.77	2.2
Total Long-Term Assets	10.49	5.73
Total Assets	196.29	211.73
Accounts Payable	6.34	10.3
Other Current Liabilities	28.74	29.8
Total Current Liabilities	35.08	40.09
Other Long-Term Liabilities	3.79	1.81
Total Long-Term Liabilities	3.79	1.81
Total Liabilities	38.87	41.9
Retained Earnings	-125.38	-99.12
Comprehensive Income	0.26	-0.23
Shareholders' Equity	-97.7	-85.29
Net Cash / Debt	149.31	163.14
Net Cash / Debt Growth	-8.48%	-
Net Cash Per Share	4.02	4.77
Working Capital	150.73	165.92
Book Value Per Share	-2.63	-2.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).